Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

NCT00688246 · clinicaltrials.gov ↗
COMPLETED
Status
238
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

NCIC Clinical Trials Group